Lineage Cell Therapeutics, Inc. (LCTX)
1.81
+0.03
(+1.69%)
USD |
NYAM |
Feb 20, 16:00
1.81
0.00 (0.00%)
After-Hours: 20:00
Lineage Cell Therapeutics Profit Margin (Quarterly) : -808.3% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Nephros, Inc. | 7.07% |
| ProKidney Corp. | -16.52K% |
| ACADIA Pharmaceuticals, Inc. | 25.76% |
| Agenus, Inc. | -- |
| Alnylam Pharmaceuticals, Inc. | 16.99% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -117.5% |
| Return on Assets | -67.24% |
| Return on Invested Capital | -112.6% |
| Gross Profit Margin (Quarterly) | 95.03% |
| Operating Margin (Quarterly) | -102.9% |
| Return on Net Operating Assets | -120.6% |